These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3044040

  • 1. Evaluation of lopamidol and diatrizoate in excretory urography: a double-blind clinical study.
    Cochran ST, Ballard JW, Katzberg RW, Barbaric ZL, Spataro R, Iwamoto K, Lee JJ.
    AJR Am J Roentgenol; 1988 Sep; 151(3):523-7. PubMed ID: 3044040
    [Abstract] [Full Text] [Related]

  • 2. Double-blind comparison of iodamide and diatrizoate for excretory urography.
    Rosenfield AT, Putman CE, Ulreich S, Koss N.
    Yale J Biol Med; 1977 Sep; 50(6):631-6. PubMed ID: 345632
    [Abstract] [Full Text] [Related]

  • 3. Iohexol for excretory urography: a comparative study.
    Winfield AC, Dray RJ, Kirchner FK, Muhletaler CA, Price RR.
    AJR Am J Roentgenol; 1983 Sep; 141(3):571-3. PubMed ID: 6349311
    [Abstract] [Full Text] [Related]

  • 4. Iopamidol: new, nonionic contrast agent for excretory urography.
    Thompson WM, Foster WL, Halvorsen RA, Dunnick NR, Rommel AJ, Bates M.
    AJR Am J Roentgenol; 1984 Feb; 142(2):329-32. PubMed ID: 6607602
    [Abstract] [Full Text] [Related]

  • 5. Iohexol vs. diatrizoate. A comparative study in intravenous urography.
    Rankin RN, Eng FW.
    Invest Radiol; 1985 Feb; 20(1 Suppl):S112-4. PubMed ID: 3972525
    [Abstract] [Full Text] [Related]

  • 6. A double-blind study comparing the efficiency, tolerance and renal effects of iopromide and iopamidol.
    Kennedy C, Rickards D, Lee S, Sharp MB, Dawson P.
    Br J Radiol; 1988 Apr; 61(724):288-93. PubMed ID: 3285943
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Excretory urography: comparison of the ionic contrast medium amidotrezoic acid with the non-ionic contrast medium iohexol].
    Grabenwöger F, Dock W, Pinterits F, Metz V.
    Wien Med Wochenschr; 1989 Feb 15; 139(3):48-50. PubMed ID: 2650470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of iopamidol and diatrizoate in excretory urography: a double-blind clinical study.
    Beam C, Dunnick NR.
    Invest Radiol; 1990 Nov 15; 25(11):1255-7. PubMed ID: 2254061
    [No Abstract] [Full Text] [Related]

  • 11. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy].
    Kondo K, Kamidono S, Hamami G.
    Hinyokika Kiyo; 1988 Oct 15; 34(10):1845-51. PubMed ID: 3245531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K, Kunadian B, Wright RA, Hall JA, Stewart MJ, Davies A, Sutton A, de Belder MA.
    Eur J Radiol; 2007 Feb 15; 61(2):342-50. PubMed ID: 17101256
    [Abstract] [Full Text] [Related]

  • 14. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK, Kopecky KK, Bogan M, Wass JL.
    Urol Radiol; 1990 Feb 15; 12(3):168-72. PubMed ID: 2281582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K, Hruby W, Assinger S, Luckner H.
    Radiologe; 1984 Oct 15; 24(10):488-90. PubMed ID: 6505221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.